Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Thomas

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
The European Journal of Neuroscience|May 19, 2004
Nicotine reduces A beta in the brain and cerebral vessels of APPsw miceEwa Hellström-Lindahl, Jennifer Court, Jessica Keverne, et al.
The American Journal of Psychiatry|June 19, 2015
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-AnalysisChris Stinton, Ian McKeith, John-Paul Taylor, et al.
Pilot and Feasibility Studies|December 15, 2016
Lessons from a pilot and feasibility randomised trial in depression (Blood pressure Rapid Intensive Lowering And Normal Treatment for Mood and cognition in persistent depression (BRILiANT mood study))Kirsty Olsen, Denise Howel, Robert Barber, et al.
Psychological Medicine|June 24, 2025
Progression of clinical diagnostic features and cognitive decline in mild cognitive impairment with Lewy bodiesCalum Alexander Hamilton, Paul C Donaghy, John-Paul Taylor, et al.
Neurobiology of Aging|December 11, 2020
Genetic variants in glutamate-, Aβ-, and tau-related pathways determine polygenic risk for Alzheimer's diseaseTed Lawingco, Sultan Chaudhury, Keeley J Brookes, et al.
Acta Neuropathologica|February 14, 2024
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic changeNauman Malik, Mohi-Uddin Miah, Alessandro Galgani, et al.
The Journal of Clinical Psychiatry|January 28, 2004
A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcomeClive G Ballard, Alan Thomas, Jane Fossey, et al.
International Journal of Geriatric Psychiatry|November 18, 2003
What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementiaThaís S C Minett, Alan Thomas, Lucy M Wilkinson, et al.
Aging & Mental Health|June 6, 2022
Predictors of loneliness during the Covid-19 pandemic in people with dementia and their carers in England: findings from the DETERMIND-C19 studyRotem Perach, Sanna Read, Ben Hicks, et al.
Neurology|January 2, 2015
Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid loadPietro Tiraboschi, Johannes Attems, Alan Thomas, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
The European Journal of Neuroscience|May 19, 2004
Nicotine reduces A beta in the brain and cerebral vessels of APPsw miceEwa Hellström-Lindahl, Jennifer Court, Jessica Keverne, et al.
The American Journal of Psychiatry|June 19, 2015
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-AnalysisChris Stinton, Ian McKeith, John-Paul Taylor, et al.
Pilot and Feasibility Studies|December 15, 2016
Lessons from a pilot and feasibility randomised trial in depression (Blood pressure Rapid Intensive Lowering And Normal Treatment for Mood and cognition in persistent depression (BRILiANT mood study))Kirsty Olsen, Denise Howel, Robert Barber, et al.
Psychological Medicine|June 24, 2025
Progression of clinical diagnostic features and cognitive decline in mild cognitive impairment with Lewy bodiesCalum Alexander Hamilton, Paul C Donaghy, John-Paul Taylor, et al.
Neurobiology of Aging|December 11, 2020
Genetic variants in glutamate-, Aβ-, and tau-related pathways determine polygenic risk for Alzheimer's diseaseTed Lawingco, Sultan Chaudhury, Keeley J Brookes, et al.
Acta Neuropathologica|February 14, 2024
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic changeNauman Malik, Mohi-Uddin Miah, Alessandro Galgani, et al.
The Journal of Clinical Psychiatry|January 28, 2004
A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcomeClive G Ballard, Alan Thomas, Jane Fossey, et al.
International Journal of Geriatric Psychiatry|November 18, 2003
What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementiaThaís S C Minett, Alan Thomas, Lucy M Wilkinson, et al.
Aging & Mental Health|June 6, 2022
Predictors of loneliness during the Covid-19 pandemic in people with dementia and their carers in England: findings from the DETERMIND-C19 studyRotem Perach, Sanna Read, Ben Hicks, et al.
Neurology|January 2, 2015
Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid loadPietro Tiraboschi, Johannes Attems, Alan Thomas, et al.
Pageof 11